Sign in

CIK 0001404281

  • Non-accelerated filer
  • Smaller reporting company

Eledon Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 949-238-8090
Business address
19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
Former names
Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-09-12 TURKEL CATHERINE C. President Purchase +16,632 $5.02 $83K 78,199
2018-09-11 TURKEL CATHERINE C. President Purchase +17,048 $4.56 $78K 61,567
2018-09-05 TURKEL CATHERINE C. President Purchase +805 $3.97 $3K 805
2017-05-10 FLESHER GREGORY J. Chief Executive Officer Purchase +58,959 $9.99 $589K 115,856
2017-05-10 TURKEL CATHERINE C. Chief Development Officer Purchase +11,111 $9.99 $111K 24,519
2017-05-10 OCAMPO CHRISTINE Purchase +10,010 $9.99 $100K 21,590
2016-03-15 Buckley Stephen Jr. Director Purchase +8,000 $5.74 $46K 11,000
2015-11-11 Buckley Stephen Jr. Director Purchase +3,000 $11.25 $34K 3,000
2014-09-22 Satter Muneer A 10% owner Purchase +150,000 $15.00 $2.3M 1,771,688
2014-09-22 Apple Tree Partners II - Annex, L.P. Director Purchase +237,500 $15.00 $3.6M 3,568,438
2014-09-22 Harrison Seth Loring Director Purchase +362,500 $15.00 $5.4M 7,912,079
2014-09-22 Novartis Bioventures Ltd 10% owner Purchase +325,000 $15.00 $4.9M 4,644,328

Page 2 of 2 · 32 trades